1. Home
  2. PTIX vs AIHS Comparison

PTIX vs AIHS Comparison

Compare PTIX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • AIHS
  • Stock Information
  • Founded
  • PTIX 1994
  • AIHS 2014
  • Country
  • PTIX United States
  • AIHS China
  • Employees
  • PTIX N/A
  • AIHS N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • PTIX Health Care
  • AIHS Finance
  • Exchange
  • PTIX Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • PTIX 2.8M
  • AIHS 3.0M
  • IPO Year
  • PTIX 2016
  • AIHS 2018
  • Fundamental
  • Price
  • PTIX $2.78
  • AIHS $2.15
  • Analyst Decision
  • PTIX
  • AIHS
  • Analyst Count
  • PTIX 0
  • AIHS 0
  • Target Price
  • PTIX N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • PTIX 104.7K
  • AIHS 43.0K
  • Earning Date
  • PTIX 08-22-2025
  • AIHS 08-26-2025
  • Dividend Yield
  • PTIX N/A
  • AIHS N/A
  • EPS Growth
  • PTIX N/A
  • AIHS N/A
  • EPS
  • PTIX N/A
  • AIHS N/A
  • Revenue
  • PTIX N/A
  • AIHS $3,389,072.00
  • Revenue This Year
  • PTIX N/A
  • AIHS N/A
  • Revenue Next Year
  • PTIX N/A
  • AIHS N/A
  • P/E Ratio
  • PTIX N/A
  • AIHS N/A
  • Revenue Growth
  • PTIX N/A
  • AIHS N/A
  • 52 Week Low
  • PTIX $2.35
  • AIHS $2.10
  • 52 Week High
  • PTIX $15.54
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 41.42
  • AIHS 30.19
  • Support Level
  • PTIX $2.60
  • AIHS $2.10
  • Resistance Level
  • PTIX $3.24
  • AIHS $2.35
  • Average True Range (ATR)
  • PTIX 0.27
  • AIHS 0.19
  • MACD
  • PTIX 0.02
  • AIHS 0.07
  • Stochastic Oscillator
  • PTIX 27.69
  • AIHS 5.68

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: